This inventor holds 1 USPTO granted patent. Top assignee: Celltech R&d Limited. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: The Innovations of Nigel Robert Arnold Beeley
Introduction
Nigel Robert Arnold Beeley is a notable inventor based in Thame, GB. He has made significant contributions to the field of biotechnology, particularly in the development of antigen-binding proteins. His work has implications for the treatment and diagnosis of serious health conditions, including cancer.
Latest Patents
One of Beeley's key patents is titled "Tri- and tetra-valent monospecific antigen-binding proteins." This invention provides a tri- or tetra-valent monospecific antigen-binding protein comprising three or four Fab fragments bound to each other covalently by a connecting structure. Notably, this protein is not a natural immunoglobulin. The patent also introduces novel connecting structures for assembling these proteins and methods for attaching labeling or effector groups. The proteins developed through this invention are particularly useful in medical applications, especially in cancer treatment and diagnosis.
Career Highlights
Nigel Robert Arnold Beeley is associated with Celltech R&D Limited, where he continues to innovate and contribute to advancements in biotechnology. His work at Celltech has positioned him as a key player in the development of therapeutic solutions that leverage his patented technologies.
Collaborations
Beeley has collaborated with several professionals in his field, including Alison Turner and Thomas A Millican. These collaborations have likely enhanced the scope and impact of his research and inventions.
Conclusion
Nigel Robert Arnold Beeley is a distinguished inventor whose work in antigen-binding proteins has the potential to revolutionize cancer treatment and diagnosis. His contributions to biotechnology are noteworthy and continue to influence the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
